ARTICLE | Company News
Nabi Biopharmaceuticals Inc., Braintree deal
August 11, 2003 7:00 AM UTC
NABI completed its previously announced acquisition of worldwide rights to Braintree's PhosLo calcium acetate, which is marketed to control elevated phosphate levels (hyperphosphatemia) in patients w...